Latest Warrants News

Askari Metals is advancing its African exploration strategy with detailed field campaigns targeting tin, tantalum, and gold mineralisation in Namibia and Ethiopia, while evaluating strategic acquisitions to bolster its portfolio.

Trading in Alphinity Global Equity Fund's Active ETF (XALG) has been temporarily halted, with personal trading also paused pending further announcements.

Recce Pharmaceuticals has locked in a non-dilutive A$30 million debt facility with Avenue Capital Group, extending its cash runway to support pivotal Phase 3 trials and commercialisation of its synthetic anti-infective R327G.

AMP Limited has announced a quarterly distribution of AUD 1.9069 per AMP Capital Notes 2 security, payable in September 2025, reflecting a total annualised yield of 7.57%.

Amplia Therapeutics has reported a rare pathological complete response in a patient from its ACCENT trial, highlighting promising potential for its drug narmafotinib in treating advanced pancreatic cancer.

New World Resources has successfully completed a placement of 32 million shares at $0.02 each to its board and senior management, following shareholder approval. This move subtly reshapes the company’s capital structure ahead of its copper and base metals projects in the US.

Nexus Minerals has revealed a significant 1km southern extension to its Branches Prospect at the Wallbrook Gold Project, following a comprehensive 237-hole aircore drilling program. This discovery potentially doubles the known strike length of the mineralised system, underpinning an active exploration phase.

Invion Limited has addressed ASX queries over the timing and content of its cleansing notice, confirming encouraging early results from its Phase I/II non-melanoma skin cancer trial using Photosoft™ technology.

Australian Rare Earths Limited (AR3) has expanded its Overland Project by approximately 2,000 km², unveiling new copper-gold basement targets alongside ongoing uranium exploration in the highly prospective Delamerian region of South Australia.

Botanix Pharmaceuticals has secured a US$30 million debt facility from Kreos Capital, bolstering its financial position to commercialize Sofdra™ and pursue platform expansion opportunities.

The Takeovers Panel has imposed interim orders restricting key parties from dealing with shares in Mayfield Childcare Limited, signaling regulatory scrutiny over the company's affairs.

Wide Open Agriculture Limited has launched a Share Purchase Plan offering shareholders the chance to buy up to $30,000 in new shares at a discounted price, accompanied by free listed options. The offer closes on 7 July 2025.